Moderna

UPDATED: EU regulator endorses use of Moderna COVID-19 vaccine in teens

Europe's medicines regulator on Friday recommended approving the use of Moderna's COVID-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for…

Read More Here

Pfizer and Moderna vaccines to include new warnings from FDA

The U.S. Food and Drug Administration said on Wednesday it plans to move quickly to add a warning about rare cases of heart inflammation in adolescents and young adults to…

Read More Here

EU takes up option to buy 150 million more Moderna COVID-19 shots

The European Union has decided to take up an option under a supply contract with drugmaker Moderna that allows the bloc to order 150 million additional COVID-19 vaccines produced by…

Read More Here

Angela Merkel given Moderna as second COVID-19 jab after having AstraZeneca as first

Angela Merkel has received the Moderna vaccine has her second inoculation against COVID-19 having had the AstraZeneca jab as her first dose, the German Chancellor's office said. "Yes, we confirm"…

Read More Here

Heart inflammation in young men higher than expected after Pfizer, Moderna vaccines -U.S. CDC

A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer/BioNTech and Moderna, according to data from two vaccine safety…

Read More Here

Moderna seeks European approval for COVID-19 vaccine’s use in teens

Moderna Inc said on Monday it has submitted an application to the European drugs regulator seeking conditional approval for its COVID-19 vaccine's use in adolescents. A similar request was done…

Read More Here

Lonza plans new production line to make Moderna COVID-19 vaccine ingredients

Swiss contract drug manufacturer Lonza said on Wednesday that a new production line in the Netherlands will produce ingredients for Moderna's COVID-19 vaccine, part of the U.S. drugmaker's plan to…

Read More Here

Moderna raises 2021 sales forecast for COVID-19 vaccine to $19.2 billion

Moderna Inc raised its 2021 sales forecast for its COVID-19 vaccine by 4.3% to $19.2 billion, reflecting demand from countries looking to return to normalcy through rapid inoculation. Earlier…

Read More Here

Early data shows Moderna booster increases antibodies against COVID-19 variants

Moderna Inc said early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19…

Read More Here

Moderna boosting COVID-19 vaccine capacity, targets up to 3 billion shots in 2022

Moderna Inc said it is boosting manufacturing capacity for its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast. It…

Read More Here

Moderna’s EU, Swiss roll-out on track -delays expected for shipments to Britain and Canada

April 16 (Reuters) - Moderna Inc said on Friday a shortfall in COVID-19 vaccine doses from its European suppliers will delay deliveries to countries including Canada and Britain, but shipments…

Read More Here

Pfizer and Moderna decline request by J&J to study the risks of blood clots – WSJ

(Reuters) - Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, but Pfizer Inc and Moderna…

Read More Here

England to start using Moderna jab today

England will start using the Moderna vaccine on Tuesday, which will be used at over 20 sites this week as the third shot that is available in Britain for COVID-19. Health…

Read More Here

Italy could sign contract with Moderna for more vaccine doses

Italy's government is in talks with Moderna Inc and could soon sign a contract with the group for further COVID-19 vaccine doses, on top of those supplied under a broader…

Read More Here

UK begins rollout of Moderna COVID vaccine

Britain begins rolling out Moderna's COVID-19 vaccine on Wednesday in Wales and expects to be using it in the rest of the United Kingdom in the coming days in a…

Read More Here

Pfizer, Moderna COVID-19 vaccines highly effective after first shot in real-world use, U.S. study shows

COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced risk of infection by 80% two weeks or more after the first of two shots, according to data from a real-world…

Read More Here

Pfizer, Moderna vaccines reduce COVID-19 infection risk by 90% after second dose -U.S. study

The COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc are highly effective and reduced the risk of infection by 90% by two weeks after the second…

Read More Here

Moderna delays shipment of about 600,000 COVID-19 vaccine doses to Canada

Moderna Inc has delayed the shipment of 590,400 doses of its COVID-19 vaccine that were due to arrive in Canada this weekend, the federal procurement minister said. Moderna informed Canadian…

Read More Here

Moderna begins study of COVID-19 vaccine in kids

Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday. The study will assess the safety…

Read More Here

Moderna begins testing next-generation coronavirus vaccine

Moderna Inc said on Monday it had dosed the first participant in an early-stage study of a new COVID-19 vaccine candidate that could potentially be stored and shipped in refrigerators instead…

Read More Here

AstraZeneca sold out of vaccine maker Moderna last year

AstraZeneca sold a stake it held in rival COVID-19 vaccine maker Moderna over the course of last year, the Anglo-Swedish drugmaker's latest annual report shows. London-listed AstraZeneca did not specify…

Read More Here

Moderna expects $18.4 billion in COVID-19 vaccine sales in 2021

Moderna Inc said it was expecting sales of $18.4 billion from its coronavirus vaccine this year, putting it on the path to post a profit for the first time since…

Read More Here

Exclusive – EU seeks new COVID-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU – sources

BRUSSELS, Feb 15 (Reuters) - The EU is holding talks with Moderna on buying more COVID-19 vaccine and AstraZeneca, with which talks have stalled, has suggested delivering doses of its…

Read More Here

Moderna COVID vaccines delayed in Europe and elsewhere, adding to shortfalls

MILAN, Jan 29 (Reuters) - Shortfalls in COVID-19 vaccine deliveries from U.S. drugmaker Moderna have spread across Europe, as Italy joined France and Switzerland in announcing the company's shipments for…

Read More Here

Moderna says COVID-19 vaccine appears to be effective against new variants

(Reuters) - Moderna Inc said on Monday its COVID-19 vaccine produced virus-neutralizing antibodies in laboratory tests against new coronavirus variants found in the UK and South Africa. A two-dose regimen…

Read More Here

French health body recommends delaying second COVID shot to six weeks after first

France's top health advisory body on Saturday recommended doubling the time between people being given the first and second COVID-19 vaccinations to six weeks from three in order to increase…

Read More Here

California resumes Moderna COVID-19 vaccine usage after pause

California's health department said on Wednesday it was safe to continue to use a batch of COVID-19 vaccine from Moderna Inc for inoculation after a pause on Sunday due to…

Read More Here

Moderna says possible allergic reactions to COVID-19 vaccine under investigation

(Reuters) - Moderna Inc said on Tuesday it had received a report from California's health department that several people at a center in San Diego were treated for possible allergic…

Read More Here

California calls for pause in use of huge batch of Moderna vaccines after allergic reactions

California’s top epidemiologist is warning health providers to delay using a batch of the Moderna COVID-19 vaccine after a “higher-than-usual number of possible allergic reactions” were reported at a Southern…

Read More Here

Moderna Says Based On Available Evidence To Date, Vaccine Immunity Should Last At Least A Year

Immunity from Moderna Inc's COVID-19 vaccine should last at least a year, the company said on Monday at the J.P. Morgan Healthcare conference. The drugmaker said it was confident that the messenger RNA (mRNA)…

Read More Here

Swiss minister expects regulator to approve Moderna COVID shot ‘very soon’

Swiss Health Minister Alain Berset said he expects Switzerland's drugs regulator swissmedic to approve Moderna Inc's COVID-19 vaccine "very soon", suggesting a wait of just days, not weeks. "The signals…

Read More Here

EXCLUSIVE – EU seeks more Moderna COVID-19 vaccines, eyes deals with Valneva, Novavax

BRUSSELS/MILAN, Jan 11 (Reuters) - The European Union is in talks with Moderna to order more of its COVID-19 vaccine despite the company seeking a higher price, and is also…

Read More Here

Moderna vaccine enroute to Malta – Deputy PM Fearne

The first consignment of the Moderna Vaccine is set to arrive in Malta in the coming hours. https://twitter.com/chrisfearne/status/1348363369888288770 Deputy Prime Minister and Minister for Health Chris Fearne, through Twitter, shared…

Read More Here

Moderna CEO says vaccine likely to protect for ‘couple of years’

Moderna's COVID-19 mRNA vaccine is likely to offer protection of up to a couple of years, its chief executive said on Thursday, even though more data is still needed to…

Read More Here

Moderna aiming to make up to 1 bln doses of COVID-19 vaccine this year

Moderna Inc is on track to deliver between 600 million and 1 billion doses of its COVID-19 vaccine this year, Chief Executive Stephane Bancel said on Thursday. Bancel said Moderna…

Read More Here

Moderna vaccine expected to work against British variant -Dutch drugs authority

The COVID-19 vaccine developed by Moderna is expected to also be effective against the new variant of coronavirus detected in Britain, the Dutch national drugs authority CBG said on Wednesday.…

Read More Here

European drugs regulator approves Moderna coronavirus vaccine – statement

Moderna Inc's coronavirus vaccine on Wednesday became the second to receive approval from Europe's medicines regulator as authorities accelerate the roll-out of shots aimed at curbing the pandemic amid worries…

Read More Here

Moderna COVID-19 vaccine distribution started in Canada by FedEX, Innomar Strategies

Dec 24 (Reuters) - FedEx Corp's Canadian subsidiary and Innomar Strategies, a Canada-based unit of U.S. drug distributor AmerisourceBergen Corp said on Thursday they have started to distribute Moderna Inc's…

Read More Here

Update – Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaign

DETROIT/LOS ANGELES/NEW YORK, Dec 19 (Reuters) - U.S. distribution of Moderna Inc's COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as…

Read More Here

How the Moderna vaccine stacks up against Pfizer/BioNTech’s

U.S. regulators authorized Moderna Inc’s COVID-19 vaccine for emergency use on Friday, a week after granting the first U.S. authorization to Pfizer Inc and BioNTech SE’s coronavirus shot. The following…

Read More Here

US approves Moderna as second vaccine

Moderna Inc's coronavirus vaccine became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death…

Read More Here

UK secures two million more doses of Moderna’s COVID-19 vaccine

Britain has secured two million doses of Moderna Inc's COVID-19 vaccine candidate, to be available in Europe as early as the spring, the government said on Sunday, in addition to…

Read More Here

EU secures 160 million doses of Moderna’s COVID-19 vaccine

The European Union has struck a deal for up to 160 million doses of U.S. firm Moderna's COVID-19 vaccine candidate, the head of the European Commission said on Tuesday, taking…

Read More Here

Moderna sets price of vaccine to $25 – $37 per dose

Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag…

Read More Here

A closer look at Moderna’s mRNA coronavirus vaccine

Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19. It will seek emergency use…

Read More Here

UPDATED: EU welcomes Moderna vaccine result, says more supply deals to come

The European Commission said the positive results announced on Monday by U.S. biotech firm Moderna for its COVID-19 vaccine candidate was encouraging and said the bloc was working to sign…

Read More Here

UPDATED: Moderna says its vaccine is 94.5% effective in preventing COVID-19

Moderna Inc's experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report…

Read More Here

EMA starts rolling review for Moderna’s COVID-19 vaccine candidate

Europe's health regulator said on Monday it had started a real-time review of Moderna Inc's experimental vaccine for COVID-19, on the back of similar such review launches for vaccines from…

Read More Here

Switzerland starts ‘rolling review’ of Moderna COVID-19 vaccine

Switzerland has begun a rolling review of Moderna's, COVID-19 vaccine candidate so it can give it a speedy approval should it pass muster in clinical trials, the country's drug regulator…

Read More Here

EU drug watchdog won’t set minimum efficacy levels for potential COVID-19 vaccines

Europe's drug regulator will not set a minimum level of efficacy for potential COVID-19 vaccines when considering them for approval, it said on Wednesday, taking a different approach to that…

Read More Here

Moderna on track to report late-stage COVID-19 vaccine data next month

Moderna Inc said it is on track to report early data from a late-stage trial of its experimental COVID-19 vaccine next month, offering the clearest timeline yet for when the…

Read More Here

UK starts real-time review of Moderna’s COVID-19 vaccine candidate

Moderna Inc said the United Kingdom's health regulator has started a real-time review of its experimental COVID-19 vaccine. The company has begun a rolling data submission from its vaccine candidate…

Read More Here

Spain’s Rovi plans to start manufacturing Moderna vaccine ‘very soon’

Spain's pharmaceutical firm Rovi , in charge of the "fill and finish" final stage of manufacturing for Moderna's COVID-19 vaccine candidate outside the United States, said it expects to start…

Read More Here

Moderna says COVID-19 vaccine unlikely to be ready before November

Moderna Inc will not be ready to apply for emergency authorization for its potential COVID-19 vaccine before the U.S. presidential election in November, the Financial Times reported on Wednesday, citing…

Read More Here

Study shows Moderna COVID-19 vaccine appears safe, shows signs of working in older adults

Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,…

Read More Here

Moderna sees 20 million doses of COVID-19 vaccine candidate by year end

Moderna Inc announced it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500…

Read More Here

Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial

Drug developer Moderna Inc said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19 vaccine candidate. In a tweet, the company also…

Read More Here